Reducing fatigue in adults with end-stage kidney disease through relaxation and walking.
Fight Fatigue: A progressive muscle relaxation and walking intervention to reduce fatigue in adults with ESKD
['FUNDING_OTHER'] · UNIVERSITY OF ILLINOIS AT CHICAGO · NIH-11039297
This study is testing a special program that combines relaxation exercises and walking to help adults with end-stage kidney disease feel less tired and improve their overall well-being, with support through text messages to keep them on track.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT CHICAGO (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-11039297 on ClinicalTrials.gov |
What this research studies
This research aims to develop and evaluate a tailored program combining progressive muscle relaxation and walking to help reduce fatigue in adults suffering from end-stage kidney disease (ESKD). The intervention focuses on promoting whole person health by addressing the debilitating fatigue that significantly impacts the quality of life for these patients. Participants will engage in a structured program that includes both relaxation techniques and physical activity, with support provided through text messaging to enhance adherence. The study will assess how feasible and acceptable this combined approach is for individuals with ESKD.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with end-stage kidney disease and experience significant fatigue.
Not a fit: Patients who do not have end-stage kidney disease or those who are unable to participate in physical activity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective way to alleviate fatigue in adults with end-stage kidney disease, improving their overall quality of life.
How similar studies have performed: Previous research has shown that progressive muscle relaxation can effectively reduce fatigue, but this specific combination of interventions in the ESKD population is novel and has not been extensively studied.
Where this research is happening
Chicago, UNITED STATES
- UNIVERSITY OF ILLINOIS AT CHICAGO — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HANNAN, MARY — UNIVERSITY OF ILLINOIS AT CHICAGO
- Study coordinator: HANNAN, MARY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.